StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
7
Publishing Date
2023 - 05 - 09
10
2023 - 05 - 03
8
2023 - 03 - 15
9
2023 - 02 - 14
8
2023 - 01 - 31
8
2023 - 01 - 17
7
2022 - 11 - 03
7
2022 - 07 - 28
7
2022 - 06 - 23
8
2022 - 05 - 16
7
2022 - 05 - 09
8
2022 - 03 - 16
7
2022 - 02 - 24
11
2022 - 02 - 18
10
2022 - 02 - 16
7
2022 - 02 - 14
7
2022 - 02 - 10
9
2022 - 02 - 08
7
2022 - 02 - 07
8
2022 - 01 - 26
7
2021 - 12 - 20
7
2021 - 12 - 17
7
2021 - 12 - 15
7
2021 - 12 - 14
7
2021 - 12 - 13
10
2021 - 12 - 06
7
2021 - 11 - 30
9
2021 - 11 - 29
7
2021 - 11 - 23
7
2021 - 11 - 17
7
2021 - 11 - 16
8
2021 - 11 - 12
7
2021 - 11 - 10
9
2021 - 11 - 03
7
2021 - 10 - 28
7
2021 - 10 - 25
8
2021 - 10 - 22
7
2021 - 10 - 20
7
2021 - 10 - 14
9
2021 - 10 - 13
9
2021 - 10 - 04
7
2021 - 09 - 27
7
2021 - 09 - 20
10
2021 - 09 - 13
12
2021 - 09 - 01
10
2021 - 08 - 30
8
2021 - 08 - 23
9
2021 - 07 - 15
7
2021 - 06 - 28
7
2021 - 06 - 25
9
2021 - 06 - 24
9
2021 - 06 - 23
7
2021 - 06 - 18
7
2021 - 06 - 11
15
2021 - 06 - 08
7
2021 - 06 - 07
9
2021 - 05 - 24
7
2021 - 05 - 21
8
2021 - 05 - 12
14
2021 - 04 - 20
7
Sector
Communications
1
Health technology
4
Process industries
1
Technology services
1
Tags
Acquisition
8
Acquisition corp
4
Air
7
Alliances
5
Als
16
Application
6
Awards
5
Biotech
6
Biotech-bay
6
California
4
Cancer
5
Ce mark
4
Cel
10
Clearance
4
Clinical-trials-phase-iii
7
Collaboration
4
Conference
8
Covid
11
Covid-19
10
Deadline
4
Device
5
Disease
5
Drug
8
Ema
14
Energy
13
Europe
7
Events
6
Expansion
5
Fda
5
Food
5
Group
13
Growth
13
Health
6
Iot
7
Life science
5
Media
5
N/a
280
Offering
6
Order
5
Partnership
9
People
7
Pharm-country
5
Phase 1
6
Phase 2
10
Phase 3
9
Platform
6
Positive
7
Pre-clinical
5
Preclinical
5
Research
15
Results
19
Solar
5
Technology
14
Test
5
Therapeutics
18
Therapy
8
Topline
5
Treatment
8
Trial
16
Vaccine
6
Entities
Alnylam pharmaceuticals, inc.
1
Amcor plc
1
Ascendis pharma a/s
1
Chinook therapeutics, inc.
1
Epam systems, inc.
1
Mainz biomed b.v.
1
Orange
1
Sanofi
1
Si-bone, inc.
1
Silgan holdings inc.
1
Stryker corporation
1
Symbols
ALNY
1
AMCR
1
ASND
1
EPAM
1
FNCTF
1
KDNY
1
MYNZ
1
SIBN
1
SLGN
1
SNY
1
SNYNF
1
SYK
1
Exchanges
Nasdaq
7
Nyse
3
Crawled Date
2021 - 12 - 14
7
Crawled Time
09:00
1
11:00
1
12:30
1
13:30
2
15:30
2
Source
www.biospace.com
4
www.globenewswire.com
1
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 12 - 14
tags :
Europe
save search
Ascendis Pharma A/S Virtual R&D Program Update Highlights Continued Development Across R&D Pipeline
Published:
2021-12-14
(Crawled : 15:30)
- biospace.com/
ASND
|
$143.18
-1.14%
-1.18%
240K
|
Health Technology
|
2.19%
|
O:
-0.56%
H:
2.19%
C:
-1.93%
pharma
EPAM Acquires Optiva Media, Expanding Presence in Western Europe & Latin America
Published:
2021-12-14
(Crawled : 15:30)
- prnewswire.com
FNCTF
|
News
|
$11.16
1.13%
-20.84%
0
|
Communications
|
8.35%
|
O:
1.65%
H:
0.0%
C:
-1.39%
EPAM
|
$245.0
-1.13%
-0.12%
700K
|
Technology Services
|
-64.23%
|
O:
-1.46%
H:
0.64%
C:
-1.76%
europe
media
Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors
Published:
2021-12-14
(Crawled : 13:30)
- biospace.com/
SYK
|
$336.85
0.58%
0.93%
1.2M
|
Health Technology
|
29.43%
|
O:
-0.77%
H:
0.39%
C:
-1.36%
SIBN
|
$15.08
-1.24%
-1.19%
380K
|
Health Technology
|
-24.22%
|
O:
-0.05%
H:
2.56%
C:
0.4%
Chinook Therapeutics Receives Orphan Drug Designation from European Commission for Atrasentan for Treatment of Primary IgA Nephropathy
Published:
2021-12-14
(Crawled : 13:30)
- biospace.com/
KDNY
|
$40.39
0.22%
-0.17%
0
|
Health Technology
|
152.2%
|
O:
-3.4%
H:
1.94%
C:
-4.85%
treatment
europe
nephropathy
drug
therapeutics
orphan drug
designation
Alnylam Submits Regulatory Applications to the U.S. Food and Drug Administration and European Medicines Agency to Support Label Expansion for OXLUMO® for the Treatment of Advanced Primary Hyperoxaluria Type 1
Published:
2021-12-14
(Crawled : 12:30)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
-3.7%
|
O:
-3.62%
H:
0.0%
C:
-0.56%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-2.38%
|
O:
-0.51%
H:
0.0%
C:
0.0%
ALNY
|
$143.8
-1.55%
-1.58%
400K
|
Health Technology
|
-18.16%
|
O:
6.02%
H:
2.03%
C:
-0.29%
oxlumo
treatment
europe
application
expansion
drug
food
32% of Growth to Originate from North America for Pharmaceutical Caps and Closures Market | By Material (plastic, metal, and rubber or cork) and Geography (North America, Europe, APAC, South America, and MEA) | 2021-2025 Analysis and Review | Technavio
Published:
2021-12-14
(Crawled : 11:00)
- prnewswire.com
AMCR
|
$9.06
0.89%
1.55%
4.3M
|
Process Industries
|
-22.0%
|
O:
0.56%
H:
0.0%
C:
0.0%
SLGN
|
$47.32
0.19%
0.0%
510K
|
Process Industries
|
11.29%
|
O:
-2.21%
H:
0.91%
C:
0.36%
europe
growth
Mainz Biomed Expands ColoAlert Commercialization with GANZIMMUN Diagnostics in Europe
Published:
2021-12-14
(Crawled : 09:00)
- globenewswire.com
MYNZ
|
$0.8987
3.42%
3.34%
5.6K
|
|
-91.08%
|
O:
-7.14%
H:
1.49%
C:
-5.34%
diagnostic
commercialization
europe
diagnostics
Gainers vs Losers
61%
39%
Top 10 Gainers
BOF
|
$2.08
77.78%
39.06%
110M
|
BHIL
|
$0.1793
-4.37%
19.24%
340K
|
Agriculture, Forestry, Fishing ...
UMAC
|
$1.48
-1.33%
14.87%
20K
|
CI
|
$352.28
-0.11%
13.53%
2
|
Health Services
CIG.C
|
$2.89
-1.37%
12.8%
2.3K
|
n/a
BMTX
4
|
$1.545
0.98%
10.03%
2.5K
|
Information
TAL
|
$12.26
0.57%
9.22%
12M
|
Consumer Services
MTH
|
$154.69
-2.21%
7.56%
64
|
Consumer Durables
ASXC
|
$0.243
-2.41%
7.0%
1.1M
|
Manufacturing
NYC
4
|
$6.03
1.86%
6.8%
0
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.